Opinion: A settlement agreement between and Federal Trade commission and Express Scripts may prove more transformative than any single pricing overhaul because it has restructured the rebate-driven ...

This story was originally published on Healthcare Dive. To receive daily news and insights, subscribe to our free daily Healthcare Dive newsletter. One of the largest pharmacy benefits managers in the ...

The nation's biggest pharmacy benefits manager is muscling back into the debate over soaring drug costs by promoting a less-expensive alternative to a life-saving medicine with a list price of $750 ...

On February 4, 2026, Express Scripts agreed to a settlement with the Federal Trade Commission (FTC) in the agency’s administrative case against the nation’s three largest pharmacy benefit managers ...

Express Scripts Holding Company ESRX announced the launch of a 12-month pilot program in fall 2018, to simplify pharmacy experience for 80 million patients. This innovative cost-effective network is ...

The Federal Trade Commission said it has reached a settlement with Express Scripts, resolving an earlier lawsuit that alleged the pharmacy benefit manager artificially inflated insulin drug prices.

The MarketWatch News Department was not involved in the creation of this content. Settlement resolves FTC lawsuit alleging that Express Scripts' conduct resulted in artificially inflated insulin drug ...

Lower drug prices offered through direct-to-consumer websites like TrumpRx are failing to reach patients with commercial ...

Grocery chain Albertsons, which offers pharmacies, is suing the Cigna-owned pharmacy benefit manager Express Scripts for at least $10.9 million over alleged prescription underpayments, according to a ...